Clinical trials
Phase 2 Cardiomyopathy, Hypertrophic trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2007 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2018 | 1 |
| 2020 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Recruiting | 3 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | 6 |
| Bristol-Myers Squibb | 2 |
| Array Biopharma, now a wholly owned subsidiary of Pfizer | 1 |
| Carelon Research | 1 |
| Cytokinetics | 1 |
| Edgewise Therapeutics, Inc. | 1 |
| Heart Metabolics Limited | 1 |
| Imbria Pharmaceuticals, Inc. | 1 |
| Lexeo Therapeutics | 1 |
| Massachusetts General Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiomyopathy, Hypertrophic | 19 |
| Cardiomyopathies | 3 |
| Cardiomegaly | 2 |
| Hypertrophy, Left Ventricular | 2 |
| Arrhythmias, Cardiac | 1 |
| Cardiomyopathy, Hypertrophic, Familial | 1 |
| Cicatrix | 1 |
| Coronary Artery Disease | 1 |
| Coronary Disease | 1 |
| Fibrosis | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.